Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

360
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
360
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

2.9K
2.9K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

851
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
851
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

505
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
505

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-antigen-targeting T cells in pediatric central nervous system tumors: a phase 1 trial.

Nature medicine·2026
Same author

Transcriptomic Meta-Analysis and Functional Validation Identify Long Non-Coding RNAs as Modulators of Zika Virus-Mediated Oncolysis in Glioblastoma Multiforme Cell Lines.

Cells·2026
Same author

Tempered Optimism: Advances in the Precision Medicine Era for Pediatric Low-Grade Glioma.

Neuro-oncology·2026
Same author

Multi-Institutional Annotated Multiparametric MRI Dataset of Pediatric High-Grade Gliomas.

Radiology. Artificial intelligence·2026
Same author

QUANTITATIVE METRICS FOR BENCHMARKING MEDICAL IMAGE HARMONIZATION.

Proceedings. IEEE International Symposium on Biomedical Imaging·2026
Same author

Molecular and clinical stratification of astroblastomas: Three distinct fusion-defined groups informing risk-adapted treatment strategies.

Neuro-oncology·2025
Same journal

Key Considerations in Telestroke Program Management.

Continuum (Minneapolis, Minn.)·2026
Same journal

Neurology's Action Potential: Delivering on the Promise of Brain Health.

Continuum (Minneapolis, Minn.)·2026
Same journal

Erratum.

Continuum (Minneapolis, Minn.)·2026
Same journal

Management of Large Artery Atherosclerosis.

Continuum (Minneapolis, Minn.)·2026
Same journal

Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke.

Continuum (Minneapolis, Minn.)·2026
Same journal

Stroke in Children and Younger Adults.

Continuum (Minneapolis, Minn.)·2026
See all related articles

Related Experiment Video

Updated: Apr 15, 2026

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
07:44

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device

Published on: May 2, 2025

1.2K

Pediatric brain tumors.

Elizabeth M Wells, Roger J Packer

    Continuum (Minneapolis, Minn.)
    |April 4, 2015
    PubMed
    Summary
    This summary is machine-generated.

    Pediatric brain tumors have unique presentations and molecular profiles. Advances in understanding and targeted therapies are improving outcomes, especially for medulloblastoma, while research continues for other childhood brain tumor types.

    More Related Videos

    Creating Anatomically Accurate and Reproducible Intracranial Xenografts of Human Brain Tumors
    11:14

    Creating Anatomically Accurate and Reproducible Intracranial Xenografts of Human Brain Tumors

    Published on: September 24, 2014

    16.3K
    Author Spotlight: A Single-Entry Point Endoscopic Intraventricular Approach for Third Ventriculostomy and Pineal Biopsy
    03:13

    Author Spotlight: A Single-Entry Point Endoscopic Intraventricular Approach for Third Ventriculostomy and Pineal Biopsy

    Published on: June 28, 2024

    1.6K

    Related Experiment Videos

    Last Updated: Apr 15, 2026

    Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
    07:44

    Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device

    Published on: May 2, 2025

    1.2K
    Creating Anatomically Accurate and Reproducible Intracranial Xenografts of Human Brain Tumors
    11:14

    Creating Anatomically Accurate and Reproducible Intracranial Xenografts of Human Brain Tumors

    Published on: September 24, 2014

    16.3K
    Author Spotlight: A Single-Entry Point Endoscopic Intraventricular Approach for Third Ventriculostomy and Pineal Biopsy
    03:13

    Author Spotlight: A Single-Entry Point Endoscopic Intraventricular Approach for Third Ventriculostomy and Pineal Biopsy

    Published on: June 28, 2024

    1.6K

    Area of Science:

    • Pediatric neuro-oncology
    • Molecular pathology of brain tumors
    • Childhood cancer therapeutics

    Background:

    • Pediatric brain tumors exhibit distinct characteristics compared to adult counterparts.
    • Understanding the nuances of childhood brain tumors is crucial for effective management.

    Purpose of the Study:

    • To review the presentation, location, histology, molecular understanding, therapy, and outcomes of pediatric brain tumors.
    • To highlight recent advancements in the biological understanding and treatment of these tumors.

    Main Methods:

    • Review of current literature on pediatric brain tumors.
    • Analysis of diagnostic workup strategies based on tumor characteristics and location.
    • Evaluation of therapeutic approaches including surgery, radiation, and chemotherapy.

    Main Results:

    • Improved biological insights are driving new molecular classifications and targeted therapies for pediatric brain tumors.
    • Survival rates for pediatric brain tumors, notably medulloblastoma, have increased due to enhanced surgical techniques and multimodal therapy.
    • Ongoing research focuses on maintaining survival while minimizing treatment-related neurological deficits in young children.

    Conclusions:

    • Pediatric brain tumor presentation and diagnosis are influenced by tumor type, location, and patient age.
    • Molecular advancements are poised to significantly impact future classification, risk stratification, and treatment paradigms.
    • While outcomes have improved for some pediatric brain tumors, further research is needed for others.